Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment
- 31 August 1995
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 130 (2), 359-366
- https://doi.org/10.1016/0002-8703(95)90454-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- First‐Line Therapy Option with Low‐Dose Bisoprolol Fumarate and Low‐Dose Hydrochlorothiazide in Patients with Stage I and Stage II Systemic HypertensionThe Journal of Clinical Pharmacology, 1995
- A Multifactorial Trial Design to Assess Combination Therapy in HypertensionArchives of Internal Medicine, 1994
- Treatment of Mild Hypertension StudyJama-Journal Of The American Medical Association, 1993
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of Internal Medicine, 1993
- The Place of Combination Therapy in the Treatment of Hypertension in 1993Clinical and Experimental Hypertension, 1993
- Recommendations for Routine Blood Pressure Measurement by Indirect Cuff SphygmomanometryAmerican Journal of Hypertension, 1992
- Multicenter Evaluation of the Hemodynamic Effects of Bisoprolol in Patients with Mild to Moderate HypertensionThe Journal of Clinical Pharmacology, 1990
- A Comparison of the Efficacy and Safety of a β-Blocker, a Calcium Channel Blocker, and a Converting Enzyme Inhibitor in Hypertensive BlacksArchives of Internal Medicine, 1990
- Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinationsJournal of Hypertension, 1990
- The Effects of Antihypertensive Therapy on the Quality of LifeThe New England Journal of Medicine, 1986